cupric chloride has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, CC; Chuang, CL; Cooper, GJ; Phillips, AR; Soon, CY; Zhang, S | 1 |
| Andican, G; Burçak, G; Civelek, S; Gelişgen, R; Küçük, SH; Ozdoğan, M; Seven, A | 1 |
2 other study(ies) available for cupric chloride and Alloxan Diabetes
| Article | Year |
|---|---|
Low-dose copper infusion into the coronary circulation induces acute heart failure in diabetic rats: New mechanism of heart disease.
Topics: Animals; Cardiac Output; Chelating Agents; Copper; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Heart; Heart Failure; In Vitro Techniques; Infusions, Intra-Arterial; Male; Models, Biological; Perfusion; Rats, Wistar; Stroke Volume; Up-Regulation; Vascular Resistance; Vasoconstriction; Ventricular Dysfunction, Left | 2015 |
Advanced glycation end products and antioxidant status in nondiabetic and streptozotocin induced diabetic rats: effects of copper treatment.
Topics: Animals; Antioxidants; Copper; Diabetes Mellitus, Experimental; Dietary Supplements; Disease Models, Animal; Glutathione; Glycation End Products, Advanced; Lipid Peroxidation; Male; Rats; Rats, Wistar; Streptozocin; Thiobarbiturates | 2010 |